Roche Holdings Inc. DL-Notes 2018(18/28) Reg.S

Type of financial instrument

Corporate Bond

Sub-Type

Health Care

Yield

4.64

Yield spread Bundesanleihe

1.8629

Tradable for private investors

No

Minimum amount tradeable unit

200,000.00

Maturity

17/09/2028

Interest Rate

3.625 %

Currency

US Dollar

Facts & figures

Price data

TRADE PLATFORM
LAST PRICE / YIELD98.067 G / 4.640 Units
PRICE DETERMINATION TIME07/27/2026 / 08:02:10 PM
DAILY VOLUME (NOMINAL)0
YIELD SPREAD1.8629
FIXINGPRICE-
DAILY HIGH / LOW98.1398.01
PREV. DAY'S PRICE97.988 (07/24)
CHANGE DAY BEFORE
+0.08
0.08 %
52 WEEK HIGH / LOW99.86 (10/17)97.92 (07/24)

Master Data

WKN
A2RRT0
ISIN
USU75000BP05
SYMBOL
-
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Corporate Bond
SUB-TYPEHealth Care
ISSUER
Roche Holdings Inc.
S&P RATINGPlease log in to view this field
(TRADING) SEGMENT / TICKS
-/ -
TRADING HOURS
07:30:00 AM - 10:00:00 PM
INTEREST RATE
3.625 %
INTEREST RUN FROM
17/09/2018
NEXT INTEREST PAYMENT
17/09/2026
UNIT INTEREST FROM NOMINAL AMMOUNT
1.329 %
TRADING CURRENCY / NOTATION
US Dollar/ Percent
NOMINAL CURRENCY
US Dollar
SETTLEMENT CURRENCY
Euro
QUOTATION
Continuous trading
ISSUING VOLUME
650.00 Mil.
MINIMUM AMOUNT TRADEABLE UNIT
200,000.00
SMALLEST TRADEABLE UNIT
1,000.00
MATURITY
17/09/2028
MARKET MAKER
-
STEP UP/ DOWN WHEN RATING CHANGES
No
STEP UP FIXED AT ISSUE
No
STEP DOWN FIXED AT ISSUE
No
BOND CALLABLE BY THE ISSUER
Yes
BOND IS SUBORDINATED
No

Description

Local currency bond: USD. Make Whole Call Option. Callable bond.

Tradability Information

Please log in to see the tradability information for this stock.

Not registered yet? Create your free account here.

Company profile

Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.